139 related articles for article (PubMed ID: 30588989)
1. Short-course metronidazole-induced reversible acute neurotoxicity in a renal transplant recipient.
Dogra PM; Bhatt AK; Agarwal SK; Bhowmik D
Saudi J Kidney Dis Transpl; 2018; 29(6):1511-1514. PubMed ID: 30588989
[TBL] [Abstract][Full Text] [Related]
2. Reversible metronidazole-induced cerebellar toxicity in a multiple transplant recipient.
Graves TD; Condon M; Loucaidou M; Perry RJ
J Neurol Sci; 2009 Oct; 285(1-2):238-40. PubMed ID: 19560788
[TBL] [Abstract][Full Text] [Related]
3. Reversible metronidazole-induced neurotoxicity after 10 weeks of therapy.
AlDhaleei W; AlMarzooqi A; Gaber N
BMJ Case Rep; 2018 Apr; 2018():. PubMed ID: 29678819
[TBL] [Abstract][Full Text] [Related]
4. Potential elevation of tacrolimus trough concentrations with concomitant metronidazole therapy.
Page RL; Klem PM; Rogers C
Ann Pharmacother; 2005 Jun; 39(6):1109-13. PubMed ID: 15855244
[TBL] [Abstract][Full Text] [Related]
5. A patient with lupus miliaris disseminatus faciei treated successfully with a combination of oral metronidazole and topical tacrolimus.
Nomura H; Egami S; Kasai H; Yokoyama T; Fujimoto A; Sugiura M
J Dermatol; 2014 Jul; 41(7):645-6. PubMed ID: 24931738
[No Abstract] [Full Text] [Related]
6. Metronidazole-induced encephalopathy: an uncommon scenario.
Chakrabarti S; Pan K
N Z Med J; 2014 May; 127(1393):120-2. PubMed ID: 24816962
[TBL] [Abstract][Full Text] [Related]
7. Falsely abnormally elevated blood trough concentration of tacrolimus measured by antibody-conjugated magnetic immunoassay in a renal transplant recipient: a case report.
Toraishi T; Takeuchi H; Nakamura Y; Konno O; Yokoyama T; Iwamoto H; Hama K; Hirano T; Unezaki S; Okuyama K; Shimazu M
Transplant Proc; 2012 Jan; 44(1):134-6. PubMed ID: 22310597
[TBL] [Abstract][Full Text] [Related]
8. Comparative analysis for optimizing the modified release tacrolimus (Advagraf) after kidney transplantation: A prospective randomized trial.
Bakr MA; Nagib AM; Donia AF; Denewar AA; Abu-Elmagd MM; Abbas MH; Abdel-Rahman AM; Mashaly ME; Elsaftawy MM; Ghoneim MA
Saudi J Kidney Dis Transpl; 2018; 29(6):1267-1273. PubMed ID: 30588956
[TBL] [Abstract][Full Text] [Related]
9. Metronidazole-induced neurotoxicity in 26 dogs.
Tauro A; Beltran E; Cherubini GB; Coelho AT; Wessmann A; Driver CJ; Rusbridge CJ
Aust Vet J; 2018 Dec; 96(12):495-501. PubMed ID: 30478843
[TBL] [Abstract][Full Text] [Related]
10. Marked elevation of blood cyclosporin and tacrolimus levels due to concurrent metronidazole therapy.
Herzig K; Johnson DW
Nephrol Dial Transplant; 1999 Feb; 14(2):521-3. PubMed ID: 10069238
[No Abstract] [Full Text] [Related]
11. Comparative clinical trial of the variability factors of the exposure indices used for the drug monitoring of two tacrolimus formulations in kidney transplant recipients.
Marquet P; Albano L; Woillard JB; Rostaing L; Kamar N; Sakarovitch C; Gatault P; Buchler M; Charpentier B; Thervet E; Cassuto E
Pharmacol Res; 2018 Mar; 129():84-94. PubMed ID: 29229354
[TBL] [Abstract][Full Text] [Related]
12. Effects of elevated tacrolimus trough levels in association with infectious enteritis on graft function in renal transplant recipients.
Nakamura A; Amada N; Haga I; Tokodai K; Kashiwadate T
Transplant Proc; 2014; 46(2):592-4. PubMed ID: 24656020
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic drug monitoring of once-daily tacrolimus (Advagraf) in a gastrectomized kidney transplant recipient.
Ma TK; Chow KM; Kwan BC; Leung CB; Szeto CC; Li PK
Nephrology (Carlton); 2017 Feb; 22(2):184. PubMed ID: 28064453
[No Abstract] [Full Text] [Related]
14. Central pontine myelinolysis (CPM) associated with tacrolimus (FK506) after liver transplantation.
Fukazawa K; Nishida S; Aguina L; Pretto E
Ann Transplant; 2011; 16(3):139-42. PubMed ID: 21959523
[TBL] [Abstract][Full Text] [Related]
15. Severe elevations of FK506 blood concentration due to diarrhea in renal transplant recipients.
Sato K; Amada N; Sato T; Miura S; Ohashi Y; Sekiguchi S; Satomi S; Okazaki H
Clin Transplant; 2004 Oct; 18(5):585-90. PubMed ID: 15344965
[TBL] [Abstract][Full Text] [Related]
16. Effect of metronidazole use on tacrolimus concentrations in transplant patients treated for Clostridium difficile.
Early CR; Park JM; Dorsch MP; Pogue KT; Hanigan SM
Transpl Infect Dis; 2016 Oct; 18(5):714-720. PubMed ID: 27501504
[TBL] [Abstract][Full Text] [Related]
17. Tacrolimus trough-level variability predicts long-term allograft survival following kidney transplantation.
O'Regan JA; Canney M; Connaughton DM; O'Kelly P; Williams Y; Collier G; deFreitas DG; O'Seaghdha CM; Conlon PJ
J Nephrol; 2016 Apr; 29(2):269-276. PubMed ID: 26374111
[TBL] [Abstract][Full Text] [Related]
18. Tacrolimus trough levels and level-to-dose ratio in stable renal transplant patients converted to a once-daily regimen.
Meçule A; Tinti F; Poli L; Bachetoni A; Umbro I; Nofroni I; Lai Q; Pretagostini R; Berloco PB; Mitterhofer AP
Transplant Proc; 2011 May; 43(4):1024-7. PubMed ID: 21620042
[TBL] [Abstract][Full Text] [Related]
19. Medication neurotoxicity in children.
Iyer RS; Chaturvedi A; Pruthi S; Khanna PC; Ishak GE
Pediatr Radiol; 2011 Nov; 41(11):1455-64. PubMed ID: 21785849
[TBL] [Abstract][Full Text] [Related]
20. Uncommon reaction to a common prescription.
Khodakaram K; Barmano N
Lancet; 2011 Jul; 378(9787):288. PubMed ID: 21763942
[No Abstract] [Full Text] [Related]
[Next] [New Search]
